In conclusion, in a sample of patients attended due to their high vascular risk in a tertiary hospital, elevated levels of Lp(a) were associated with a diagnosis of peripheral arterial disease, PFH and CHF, and with the use of more intensive lipid-lowering treatments. This evidence concerns the gene LPA and peripheral arterial disease.